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Mucocutaneous manifestations and the relationship to CD4 lymphocyte counts among
Turkish HIV/AIDS patients in İstanbul, Turkey
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Background/aim: Dermatologic findings differ among countries but no sufficient data about Turkish HIV-infected patients exist in
the literature. Therefore, our aim in this study was to document the dermatologic manifestations and their relationships with CD4 cell
counts among HIV/AIDS patients visiting our clinic for the first time in İstanbul, Turkey.
Materials and methods: A retrospective analysis of 306 HIV/AIDS patients (260 men, mean age: 38.3 years) was done in a tertiary
hospital in İstanbul from January 2006 to September 2012. Information on age, sex, transmission routes, socioeconomic and educational
status, CD4 counts, and dermatologic findings was collected retrospectively from medical records.
Results: Our analyses revealed at least 1 dermatologic disease in 111 of the 306 (36.2%) patients. Mean CD4 count of the patients was
393.64 cells/mm3 (range: 4–1270 cells/mm3). Oral candidiasis (12.4%), herpes zoster (5.9%), dermatophytosis (5.4%), hyperpigmentation
(5.2%), and folliculitis (4.6%) were the most common skin problems. Statistically significant correlation (P < 0.05) with low CD4 cell
counts was found for oral candidiasis, folliculitis, herpes zoster, hyperpigmentation, xerosis, and Kaposi’s sarcoma.
Conclusion: Dermatologic manifestations in this study were identical to those described in most studies from Asia, and there were
more manifestations as the HIV infection progressed and immune functions declined.
Key words: Mucocutaneous findings, HIV/AIDS, CD4 lymphocyte counts

1. Introduction
Since 1981, when the first reports about AIDS were
published in the medical literature, mucocutaneous
diseases have played an important role in the initial
diagnosis of HIV infection and in determining the clinical
stage of the disease. Skin can serve as the main indicator
of other problems. In up to 90% or more of HIV-positive
patients, mucocutaneous problems may develop at any
stage of the disease (1,2). Patients with advanced HIV
infection have more skin disorders than those in the early
stages. Hence, dermatologic examinations can serve as
a guide for diagnosis in terms of severity of HIV/AIDS
(1,3,4).
It is well known that mucocutaneous diseases vary
among countries, which may be attributable to climate,
endemic diseases, and hygienic standards, as well as
social, economic, and cultural factors. To date, there
have been many reports issued about the dermatologic
manifestations of HIV/AIDS patients in Western
literature. However, there is a lack of sufficient data about
* Correspondence: ozlemaa@gmail.com

dermatologic findings in Turkish HIV-infected patients.
Therefore, our aim in this study was to document the
dermatologic manifestations and their relationships with
CD4 cell counts among HIV/AIDS patients visiting our
clinic for the first time in İstanbul, a large cosmopolitan
city situated in western Turkey.
2. Materials and methods
A total of 306 newly diagnosed HIV/AIDS patients
admitted to our outpatient clinic between January 2006
and September 2012 were included in this study. All
patients were examined by an infectious diseases specialist,
and patients who had skin, mucous membrane, nail, or
hair complaints were examined by a dermatologist. All
diagnoses were based on clinical criteria supplemented by
laboratory procedures.
Information on age, sex, transmission routes,
socioeconomic and educational status, CD4 counts, and
dermatologic findings were collected retrospectively from
medical records. FACSCalibur flow cytometry (Becton
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Dickinson, USA) and a concurrent complete blood count
performed by standard techniques were used to evaluate
CD4 T-cell count and CD4/CD8 ratio.
All analyses were performed by using GraphPad Prism
5.0 and SPSS 15.0. Data were described using mean ±
standard deviation. Chi-square and Fisher’s exact tests
were used for categorical variables as appropriate. P < 0.05
was considered to be significant.
3. Results
Of the 306 HIV/AIDS patients included in this study,
260 (84.9%) were men, with a mean age of 38.3 ± 11.07
years and all patients being of Caucasian origin. The
most frequent route of transmission was heterosexual
intercourse (65.3%), followed by men having sex with men
(MSM) (33.6%); intravenous drug abuse was present in
only 3 cases. Almost half of the patients (141 (47.7%)) had
low education. The majority of the women (30 (65%)) were
housewives, whereas in men, office workers (n = 69), the
unemployed (n = 25), and drivers (n = 18) constituted the
largest group, at 112 in total (43%).
Mean CD4 count of the patients was 393.64 cells/mm3
(range: 4–1270 cells/mm3) and one-third of the patients
(33%) had CD4 counts of lower than 200/mm3. There was
at least 1 dermatologic disease in 111 (36.2%) patients. The
mean CD4 count in patients with dermatologic problems

was 292 cells/mm3 (range: 4–1189 cells/mm3). The
frequency of infectious and noninfectious manifestations,
in line with the classification of the World Health
Organization (WHO) in terms of the immunological
groups, is shown in Tables 1 and 2.
A statistically significant correlation with low CD4 cell
counts was found for oral candidiasis, folliculitis, herpes
zoster, hyperpigmentation, xerosis, and Kaposi’s sarcoma.
Out of 306 patients, 44 (14.3%) had been diagnosed
with HIV infection due to mucocutaneous diseases
before. Oral candidiasis (n = 18), Kaposi’s sarcoma (n = 7),
folliculitis (n = 6), and herpes zoster (n = 5) were the most
common diseases in these patients.
4. Discussion
In HIV infection, as a consequence of decline in the number
of antigen-presenting cells and CD4 lymphocytes, the skin
becomes vulnerable to opportunistic infectious agents
and neoplastic disorders (5). Many studies have reported
mucocutaneous manifestations in 33%–95% of HIVinfected patients (2,4,6,7). The prevalence of dermatologic
findings among our patients (36.2%) is close to that of
reports from Iran and India. The only study from Turkey
was published in 2007 and the rate of skin manifestations in
HIV/AIDS patients was 90% in that report (8). The causes
of this difference might be that the study in 2007 included

Table 1. Prevalence of infectious mucocutaneous manifestations and their relationship to CD4 counts (according to WHO immunological
staging).

Dermatologic manifestations

Number of patients,
n = 306 (%)

CD4 counts (/mm3)
≥500,
n = 67

499–350,
n = 56

349–200,
n = 82

<200,
n = 101

P-value

Fungal infections
Oral candidiasis
Onychomycosis
Tinea pedis
Tinea corporis

38 (12.4)
9 (2.9)
6 (1.9)
2 (0.6)

5
1
-

4
2
1
-

7
2
1
2

22
4
4
-

0.0001
0.042
0.046
0.046

Bacterial infections
Folliculitis
Acne vulgaris
Tuberculosis

14 (4.6)
7 (2.3)
1 (0.3)

2
3
1

3
-

1
1
-

8
3
-

0.011
0.161
-

Viral infections
Herpes zoster
Condylomata acuminata
Herpes simplex
Molluscum contagiosum

18 (5.9)
8 (2.6)
3 (0.9)
1 (0.3)

4
1
1
-

1
2
-

4
2
1
-

9
3
1
1

0.02
0.72
0.72
-

Infestations
Scabies
Pediculosis corporis

2 (0.6)
1 (0.3)

1
-

-

1
-

1

-
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Table 2. Prevalence of noninfectious mucocutaneous manifestations and the relationship to CD4 counts (according to WHO
immunological staging).

Dermatologic manifestations
Noninfectious diseases
Hyperpigmentation
Xerosis
Seborrheic dermatitis
Kaposi’s sarcoma
Psoriasis
Lichen planus
Alopecia

CD4 counts (/mm3)

Number of
patients,
n = 306 (%)

≥500,
n= 67

499–350,
n = 56

349–200,
n = 82

<200,
n = 101

P-value

16 (5.2)
15 (4.9)
13 (4.2)
8 (2.6)
2 (0.6)
2 (0.6)
1 (0.3)

2
2
-

1
1
3
2
-

4
3
2
1
1
1

11
9
6
7
1
-

0.0001
0.0016
0.108
0.0001
-

inpatients, that the number of the cases was very limited,
and that the study was made in a different geographic
region in Turkey. Nevertheless, reports from different
regions of India declared the cutaneous manifestations to
be between the range of 40%–87.6% (6,9).
In our study, infectious and noninfectious
dermatologic manifestations were recorded (see Tables 1
and 2). The most common infections were fungal, with oral
candidiasis being the most frequent. Azfar et al. and Spira
et al. showed similar rates and results; nevertheless, other
studies reported higher incidence rates of oral candidiasis,
up to 54.1% (3,10,11). The prevalence of dermatophytosis
depends on sociocultural level, climate, clothing, and
profession; there is no significant difference between the
HIV-negative and HIV-positive population (12). In our
study, dermatophytosis was documented in 5.4% of the
patients.
The most common viral infection was herpes zoster,
followed by condylomata acuminata. Shobana et al.
reported herpes zoster with a frequency of 6%, similar to
our study (6). In previous studies, condylomata acuminata
rate was determined as 3.1%–12.8% among HIV-infected
patients (13,14).
In bacterial infections, as observed in our patients,
studies have revealed frequencies of folliculitis ranging
from 3.3% to 32.9% (11,15). One of the 2 patients with
scabies was diagnosed with HIV infection due to the
crusted form of this infestation. The rate of scabies
infection has been reported to be up to 10%, especially in
pruritic eruptions (1).
Out of all the noninfectious diseases, generalized
hyperpigmentation was the most frequent finding
observed in patients. Hyperpigmentation incidence has
been reported as being low in European populations, but

high rates of incidence have been reported in Asian studies
(9,16,17). Dry skin has been noted as a common finding in
studies ranging from 22% to 73% in HIV-infected patients
(3,9,10,17). The prevalence of xerosis in our patients was
considerably lower than in the other studies.
Seborrheic dermatitis may be an early clinical marker
for HIV infection and the incidence of disease changes by
14% to 74% (4,9). In our patients, seborrheic dermatitis
was observed in all stages of HIV infection. Very high
incidences of psoriasis have been reported from Asia (up
to 25%) in HIV-infected populations (18). In Western
studies, on the other hand, 2%–4% incidences of psoriasis
have been published (6). In this study, psoriasis, lichen
planus, and alopecia were also rarely observed.
Compared to its prevalence in the 1980s and early
1990s, the rate of Kaposi’s sarcoma was relatively low
(19). Among the HIV-infected patients, MSM were the
most affected by Kaposi’s sarcoma. In our study, Kaposi’s
sarcoma was observed in 8 patients, 5 of whom were MSM.
Dermatological manifestations increased both in
frequency and severity with progression of HIV and
decline in CD4 cell counts. There was a significantly
high occurrence of oral candidiasis, hyperpigmentation,
Kaposi’s sarcoma, xerosis, folliculitis, and herpes zoster
among patients with low CD4 cell counts, which was
similar to many previous studies (3,6,9,14,20).
Here, we presented the types of skin diseases, as well
as their stages among Turkish HIV/AIDS patients. The
results suggested that oral candidiasis, Kaposi’s sarcoma,
folliculitis, and herpes zoster are useful clinical predictors
of HIV infection or signs of the presence of advanced
HIV infection. Dermatological manifestations may be the
first clue of an HIV infection and may also be helpful in
monitoring the immune status of the patient.
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